Immunohistochemical assays revealed that tumors treated with EYFs for 6 and 12 h drastically reduced the density of CD31+ microvessels and the number of Ki67+ proliferative tumor cells as well as cleaved Caspase‐3+ apoptotic tumor cells (Figure 4E). This evidence concerns the gene PECAM1 and neoplasm.